The 5th Annual LabRoots Cancer Research & Oncology Virtual Conference took place in October 2017. LabRoots invited research professionals, scientists, and clinicians to this premier online conference, making it easier and more cost-effective to learn about recent advances in cancer research. The virtual conference was free to attendees, encouraging worldwide collaboration and connections between colleagues and field experts.
Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Within the last year, we have seen progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
Cancer Research & Oncology 2017 focused on advancements in prevention, diagnosis and treatment of different cancer types. The world’s thought leaders in cancer research presented their latest discoveries in cancer mechanics and detection as well as clinical aspects such as targeted therapies and novel treatments, all in an international venue conducive to networking.
Attendees could earn free CME and CE Credits.
This virtual conference allowed participation in a global setting with no travel or cost. You could participate in exactly those parts which you were interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offered increased reach for the global cancer community with a high degree of interaction through live-streaming video and chat sessions.
Topics for this years virtual conference included:
- Computational Oncology
- Data and Bioinformatics
- Organ Systems & Oncogens
- Therapeutics and Anti-Cancer Drug Discovery
- Cancer Diagnostics, Screening and Imaging
LRcancer was the hashtag to use to follow the conversation.
Horizon exhibited at Cancer Research & Oncology.